Wang S, Wang H, Li C, Liu B, He S, Tu C
MedComm (2020). 2024; 5(3):e489.
PMID: 38469550
PMC: 10925885.
DOI: 10.1002/mco2.489.
Luo M, Gong W, Zhang Y, Li H, Ma D, Wu K
Cell Commun Signal. 2023; 21(1):347.
PMID: 38049832
PMC: 10694921.
DOI: 10.1186/s12964-023-01354-3.
Tian J, Fu W, Xie Z, Wang X, Miao M, Shan F
BMC Immunol. 2023; 24(1):38.
PMID: 37828468
PMC: 10571428.
DOI: 10.1186/s12865-023-00573-0.
Natalini A, Simonetti S, Favaretto G, Lucantonio L, Peruzzi G, Munoz-Ruiz M
Front Immunol. 2023; 14:1043631.
PMID: 36865556
PMC: 9973452.
DOI: 10.3389/fimmu.2023.1043631.
Suarez-Ramirez J, Cauley L, Chandiran K
J Immunol. 2022; 209(6):1025-1032.
PMID: 36130123
PMC: 9512391.
DOI: 10.4049/jimmunol.2200345.
SMAD4 and TGFβ are architects of inverse genetic programs during fate determination of antiviral CTLs.
Chandiran K, Suarez-Ramirez J, Hu Y, Jellison E, Ugur Z, Low J
Elife. 2022; 11.
PMID: 35942952
PMC: 9402230.
DOI: 10.7554/eLife.76457.
IL-27 improves adoptive CD8 T cells' antitumor activity via enhancing cell survival and memory T cell differentiation.
Ding M, Fei Y, Zhu J, Ma J, Zhu G, Zhen N
Cancer Sci. 2022; 113(7):2258-2271.
PMID: 35441753
PMC: 9277268.
DOI: 10.1111/cas.15374.
Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.
Dhandapani H, Seetharaman A, Jayakumar H, Ganeshrajah S, Sunder Singh S, Thangarajan R
J Gynecol Oncol. 2021; 32(4):e59.
PMID: 33908712
PMC: 8192235.
DOI: 10.3802/jgo.2021.32.e59.
Effects of Radiation on the Tumor Microenvironment.
Monjazeb A, Schalper K, Villarroel-Espindola F, Nguyen A, Shiao S, Young K
Semin Radiat Oncol. 2020; 30(2):145-157.
PMID: 32381294
PMC: 8764968.
DOI: 10.1016/j.semradonc.2019.12.004.
TGFβ suppresses CD8 T cell expression of CXCR3 and tumor trafficking.
Gunderson A, Yamazaki T, McCarty K, Fox N, Phillips M, Alice A
Nat Commun. 2020; 11(1):1749.
PMID: 32273499
PMC: 7145847.
DOI: 10.1038/s41467-020-15404-8.
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.
Formenti S, Lee P, Adams S, Goldberg J, Li X, Xie M
Clin Cancer Res. 2018; 24(11):2493-2504.
PMID: 29476019
PMC: 5999326.
DOI: 10.1158/1078-0432.CCR-17-3322.
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.
Ravi R, Noonan K, Pham V, Bedi R, Zhavoronkov A, Ozerov I
Nat Commun. 2018; 9(1):741.
PMID: 29467463
PMC: 5821872.
DOI: 10.1038/s41467-017-02696-6.
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Lee H, Kim Y, Sim C, Heo S, Song I, Park H
Oncotarget. 2018; 8(69):113345-113359.
PMID: 29371915
PMC: 5768332.
DOI: 10.18632/oncotarget.23007.
New insights into the role of EMT in tumor immune escape.
Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery J
Mol Oncol. 2017; 11(7):824-846.
PMID: 28614624
PMC: 5496499.
DOI: 10.1002/1878-0261.12093.
The Lysine Methyltransferase G9a in Immune Cell Differentiation and Function.
Scheer S, Zaph C
Front Immunol. 2017; 8:429.
PMID: 28443098
PMC: 5387087.
DOI: 10.3389/fimmu.2017.00429.
T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development.
Vahatupa M, Aittomaki S, Cordova Z, May U, Prince S, Uusitalo-Jarvinen H
Oncoimmunology. 2017; 5(12):e1245266.
PMID: 28123881
PMC: 5214164.
DOI: 10.1080/2162402X.2016.1245266.
Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
Ng S, Deng J, Chinnadurai R, Yuan S, Pennati A, Galipeau J
Cancer Res. 2016; 76(19):5683-5695.
PMID: 27488533
PMC: 5050108.
DOI: 10.1158/0008-5472.CAN-16-0386.
Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.
Dielmann A, Letsch A, Nonnenmacher A, Miller K, Keilholz U, Busse A
Cancer Immunol Immunother. 2016; 65(2):181-92.
PMID: 26753694
PMC: 11029520.
DOI: 10.1007/s00262-015-1786-1.
Transforming growth factor-β signaling is constantly shaping memory T-cell population.
Ma C, Zhang N
Proc Natl Acad Sci U S A. 2015; 112(35):11013-7.
PMID: 26283373
PMC: 4568277.
DOI: 10.1073/pnas.1510119112.
Targeting the tumor microenvironment to enhance antitumor immune responses.
Van der Jeught K, Bialkowski L, Daszkiewicz L, Broos K, Goyvaerts C, Renmans D
Oncotarget. 2015; 6(3):1359-81.
PMID: 25682197
PMC: 4359300.
DOI: 10.18632/oncotarget.3204.